215600SillaJen215600 info
$2.09info2.02%24h
Global rank19134
Market cap$147.54M
Change 7d-7.19%
YTD Performance-53.98%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Business data

    SillaJen (215600) Stock Overview

    SillaJen, Inc. engages in the development and commercialization of oncolytic immunotherapy products. The company's lead product is Pexa-Vec, which is in Phase II clinical trial for the treatment of advanced liver cancer. It also develops JX-970 for the treatment of tumor tissues; and JX-900 is a series of modified vaccinia vaccine. The company was founded in 2006 and is headquartered in Seoul, South Korea.

    215600 Stock Information

    Symbol
    215600
    Address
    O2 TowerSeoul, 07325South Korea
    Founded
    -
    Trading hours
    -
    Website
    https://www.sillajen.com
    Country
    πŸ‡°πŸ‡· South Korea
    Phone Number
    82 2 368 2600

    SillaJen (215600) Price Chart

    -
    Value:-

    SillaJen Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $2.09
    N/A
    Market Cap
    $147.54M
    N/A
    Shares Outstanding
    70.53M
    N/A
    Employees
    42.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org